|
2024
|
Invention
|
Methods for treating a p53-associated cancer. This disclosure provides compounds of Formula (I), ... |
|
|
Invention
|
Methods for treating p53-associated cancer. This disclosure provides compounds of Formula (I), Fo... |
|
|
Invention
|
Egfr inhibitors of formula (i) for use in methods of treating cancer having two or more mutations... |
|
|
Invention
|
Egfr inhibitor for use in the treatment of lung cancer positive for an egfr exon 20 mutation. Thi... |
|
|
Invention
|
Processes of preparing pi3k inhibitors. This disclosure provides processes of preparing compounds... |
|
|
Invention
|
Crystalline forms of a pi3k inhibitor and uses of same. Disclosed herein are crystalline forms of... |
|
|
Invention
|
Methods for treating cancer. This disclosure provides compounds of Formula (I), Formula (II), and... |
|
|
Invention
|
A 1,5-dihydro-4h-pyrrolo[3,2-c] pyridin-4-one for use in the treatment of cancer. The present app... |
|
|
Invention
|
A 1,5-dihydro-4h-pyrrolo[3,2-c] pyridin-4-one for use in the treatment of cancer. This present ap... |
|
2023
|
Invention
|
Combination therapy for treating cancer. This disclosure provides compounds of Formula (I), and p... |
|
|
Invention
|
Methods for treating cancer. This disclosure provides compounds of Formula (I), and pharmaceutica... |
|
|
Invention
|
Indolizine derivatives for treating cancer. This disclosure provides compounds of Formula (I), an... |
|
|
Invention
|
Pi3k-alpha inhibitors for the treatment of cancer. This disclosure provides compounds and pharmac... |
|
|
Invention
|
Methods of synthesizing egfr inhibitors. This disclosure features methods for preparing tetrahydr... |
|
|
Invention
|
Tetrahydroindole derivatives as egfr and/or her2 inhibtors useful for the treatment of cancer. Th... |
|
2022
|
Invention
|
Compounds that inhibit pi3k isoform alpha and methods for treating cancer.
This disclosure provi... |
|
|
Invention
|
Compounds that inhibit pi3k isoform alpha and methods for treating cancer. This disclosure provid... |
|
|
Invention
|
Urea derivatives which can be used to treat cancer.
This disclosure provides compounds of Formul... |
|
|
Invention
|
Urea derivatives which can be used to treat cancer. This disclosure provides compounds of Formula... |
|
|
P/S
|
Research and development in the field of cancer treatment
and related pharmaceuticals and therap... |
|
|
P/S
|
Research and development in the field of targeted and
individualized cancer treatment and relate... |
|
|
Invention
|
Bicyclic derivatives which can be used to treat cancer. This disclosure provides chemical entitie... |
|
2021
|
P/S
|
Research and development in the field of cancer treatment and related pharmaceuticals and therapies |
|
|
P/S
|
Research and development in the field of targeted and individualized cancer treatment and related... |
|
|
Invention
|
Use of macrocyclic compounds in methods of treating cancer. This disclosure provides chemical ent... |
|
|
Invention
|
Methods for treating cancer. This disclosure provides chemical entities of formula (I) (e.g., a c... |
|
|
Invention
|
Methods for treating cancer. This disclosure provides chemical entities (e.g., a compound or a ph... |
|
|
Invention
|
Heterocyclic inhibitors of egfr and/or her2, for use in the treatment of cancer. This disclosure ... |
|
|
Invention
|
Bicyclic compounds for use in the treatment cancer. This disclosure provides chemical entities (e... |
|
|
Invention
|
Pyrrolopyrolidinone and pyrroloazepinone derivatives for use in treating cancer. This disclosure ... |
|
|
Invention
|
Pyrrolo[3,2-c]pyridin-4-one derivatives useful in the treatment of cancer. This disclosure provid... |
